EPISODE · Mar 4, 2026 · 3 MIN
EP 118.捐赠、资助还是赞助？医药合规的三看原则与风险红线
from MedVerse医路人
⚖️ 同样是给钱，为什么有的叫公益捐赠，有的叫学术资助，有的却是商业赞助？本期播客将深度拆解这三大互动场景的法律边界。我们将结合辉瑞、罗氏的合规实践，详解区分捐赠与资助的三看原则，以及赞助合规的50% 红线，助您在 2026 年严苛的监管环境下，建立从资金审批到交付验收的合规闭环。🛡️ 合规避雷的核心实战点： 概念大起底 实操金标准 MNC 最佳实践 监管新趋势关于节目《MedVerse 医路人》是一档聚焦医药行业职业发展、市场与学术推广、以及行业趋势观察的播客。我们希望通过行业解析、案例分享与对话讨论，帮医药人看清职场成长的底层逻辑，找到更清晰的发展路径。找到我们公众号：MedVerse Pro小红书：达利Dali收听渠道：小宇宙、苹果Podcast、QQ音乐*扣子空间前往小宇宙评论区与主播互动
Embed this episode
Ready to play
EP 118.捐赠、资助还是赞助？医药合规的三看原则与风险红线
0:00
3:56
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of MedVerse医路人?
This episode is 3 minutes long.
When was this MedVerse医路人 episode published?
This episode was published on March 4, 2026.
Can I download this MedVerse医路人 episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!